688410 山外山
已收盘 07-10 15:00:01
资讯
新帖
简况
山外山新注册《山外山客服管理系统V2.0》等2个项目的软件著作权
证券之星 · 07-10 02:21
山外山新注册《山外山客服管理系统V2.0》等2个项目的软件著作权
每周股票复盘:山外山(688410)拟每股派现0.20元及转增0.4股
证券之星 · 07-05
每周股票复盘:山外山(688410)拟每股派现0.20元及转增0.4股
山外山(688410)披露2025年年度权益分派实施公告,7月3日股价上涨0.84%
证券之星 · 07-03
山外山(688410)披露2025年年度权益分派实施公告,7月3日股价上涨0.84%
股市必读:山外山(688410)6月30日董秘有最新回复
证券之星 · 07-01
股市必读:山外山(688410)6月30日董秘有最新回复
山外山涨6.82%,中邮证券一个月前给出“买入”评级
证券之星 · 06-29
山外山涨6.82%,中邮证券一个月前给出“买入”评级
每周股票复盘:山外山(688410)高管减持124.29万股
证券之星 · 06-28
每周股票复盘:山外山(688410)高管减持124.29万股
山外山(688410)披露2026年员工持股计划完成非交易过户公告,6月26日股价下跌3.12%
证券之星 · 06-26
山外山(688410)披露2026年员工持股计划完成非交易过户公告,6月26日股价下跌3.12%
【私募调研记录】磐耀资产调研山外山
证券之星 · 06-25
【私募调研记录】磐耀资产调研山外山
山外山(688410)披露2026年员工持股计划第一次持有人会议决议公告,6月24日股价下跌1.93%
证券之星 · 06-24
山外山(688410)披露2026年员工持股计划第一次持有人会议决议公告,6月24日股价下跌1.93%
山外山:公司通过全面推进募投项目建设,系统性地规划了未来产能提升路径
证券日报网 · 06-24
山外山:公司通过全面推进募投项目建设,系统性地规划了未来产能提升路径
山外山:公司始终重视与投资者的沟通交流
证券日报网 · 06-24
山外山:公司始终重视与投资者的沟通交流
山外山:6月11日接受机构调研,华安基金、奇盛基金等多家机构参与
证券之星 · 06-24
山外山:6月11日接受机构调研,华安基金、奇盛基金等多家机构参与
山外山(688410)6月18日股东户数1.08万户,较上期减少2.2%
证券之星 · 06-24
山外山(688410)6月18日股东户数1.08万户,较上期减少2.2%
山外山:6月18日董事高光勇减持股份合计124.29万股
证券之星 · 06-22
山外山:6月18日董事高光勇减持股份合计124.29万股
每周股票复盘:高光勇减持山外山(688410)1%股份
证券之星 · 06-20
每周股票复盘:高光勇减持山外山(688410)1%股份
山外山:6月17日董事高光勇减持股份合计84万股
证券之星 · 06-18
山外山:6月17日董事高光勇减持股份合计84万股
每周股票复盘:山外山(688410)股东户数增15.33%至1.1万户
证券之星 · 06-14
每周股票复盘:山外山(688410)股东户数增15.33%至1.1万户
每周股票复盘:山外山(688410)高管高光勇减持111.31万股
证券之星 · 06-07
每周股票复盘:山外山(688410)高管高光勇减持111.31万股
山外山最新公告:全资子公司取得血液透析干粉医疗器械变更注册文件
证券之星 · 06-05
山外山最新公告:全资子公司取得血液透析干粉医疗器械变更注册文件
6月3日山外山跌7.22%,圆信永丰医药健康A基金重仓该股
证券之星 · 06-03
6月3日山外山跌7.22%,圆信永丰医药健康A基金重仓该股
加载更多
公司概况
公司名称:
重庆山外山血液净化技术股份有限公司
所属行业:
专用设备制造业
上市日期:
2022-12-26
主营业务:
重庆山外山血液净化技术股份有限公司的主营业务是血液净化设备与耗材的研发、生产和销售,并提供连锁血液透析医疗服务。公司的主要产品是血液灌流机、连续性血液净化设备、血液透析机、血液净化设备、血液透析浓缩液、血液透析干粉、血液透析器、透析液过滤器、连续性血液净化管路、一次性使用血液灌流器。公司形成了国家级企业技术中心、国家博士后科研工作站、国家地方联合工程研究中心等科技创新平台,先后荣获“国家科学技术进步奖二等奖”等多项国家级奖项,被评为“国家技术创新示范企业”。
发行价格:
32.30
{"stockData":{"symbol":"688410","market":"SH","secType":"STK","nameCN":"山外山","latestPrice":10.3,"timestamp":1783666801000,"preClose":10.21,"halted":0,"volume":7410169,"delay":0,"changeRate":0.0088,"floatShares":447000000,"shares":447000000,"eps":0.3651,"marketStatus":"已收盘","change":0.09,"latestTime":"07-10 15:00:01","open":10.31,"high":10.68,"low":10.22,"amount":77618900,"amplitude":0.0451,"askPrice":10.31,"askSize":99,"bidPrice":10.3,"bidSize":24,"shortable":0,"etf":0,"ttmEps":0.3651,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783906200000},"marketStatusCode":5,"adr":0,"adjPreClose":10.21,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783647000000,1783654200000],[1783659600000,1783666800000]],"highLimit":11.23,"lowLimit":9.19,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":447440870,"isCdr":false,"pbRate":2.51,"roa":"--","peRate":28.211449,"roe":"3.02%","epsLYR":0.4589,"committee":0.205357,"marketValue":4609000000,"turnoverRate":0.0166,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-07-13。","afterMarket":{"amount":0,"volume":0,"close":10.3,"buyVolume":144700,"sellVolume":0,"time":1783668837746,"indexStatus":"已收盘 07-10 15:30:00","preClose":10.21},"floatMarketCap":4609000000},"requestUrl":"/m/hq/s/688410/","defaultTab":"news","newsList":[{"id":"2650979664","title":"山外山新注册《山外山客服管理系统V2.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2650979664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650979664?lang=zh_cn&edition=full","pubTime":"2026-07-10 02:21","pubTimestamp":1783621269,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山外山(688410)新注册了2个项目的软件著作权,包括《山外山客服管理系统V2.0》、《山外山SWS-4000系列主控软件V4.11》等。今年以来山外山新注册软件著作权6个。结合公司2025年年报财务数据,2025年公司在研发方面投入了6278.49万元,同比增15.75%。通过天眼查大数据分析,重庆山外山血液净化技术股份有限公司共对外投资了8家企业,参与招投标项目1250次;财产线索方面有商标信息139条,专利信息269条,著作权信息60条;此外企业还拥有行政许可60个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649928086","title":"每周股票复盘:山外山(688410)拟每股派现0.20元及转增0.4股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649928086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649928086?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:19","pubTimestamp":1783192750,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,山外山报收于15.55元,较上周的13.64元上涨14.0%。本周,山外山7月3日盘中最高价报15.88元。山外山当前最新总市值49.7亿元,在医疗器械板块市值排名68/129,在两市A股市值排名3234/5203。本周关注点公司公告汇总:山外山拟每股派发现金红利0.20元(含税),同时每股转增0.4股。公司公告汇总:本次权益分派后,山外山总股本将增至447,440,870股。公司公告汇总:山外山股权登记日为2026年7月9日,除权除息日为2026年7月10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648966129","title":"山外山(688410)披露2025年年度权益分派实施公告,7月3日股价上涨0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648966129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648966129?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:39","pubTimestamp":1783089558,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,山外山报收于15.55元,较前一交易日上涨0.84%,最新总市值为49.7亿元。该股当日开盘15.41元,最高15.88元,最低15.34元,成交额达9842万元,换手率为1.98%。近日,重庆山外山血液净化技术股份有限公司发布2025年年度权益分派实施公告:每股派发现金红利0.20元(含税),每股转增0.4股。本次权益分派以公司总股本319,600,622股为基数,共计派发现金红利63,920,124.40元,转增127,840,248股,转增后总股本为447,440,870股。公司首发战略配售股份已全部上市流通。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648598598","title":"股市必读:山外山(688410)6月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648598598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648598598?lang=zh_cn&edition=full","pubTime":"2026-07-01 06:40","pubTimestamp":1782859256,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,山外山报收于14.36元,下跌1.44%,换手率1.81%,成交量5.78万手,成交额8338.07万元。根据公司已披露的2025年年度报告,公司2025年实现营业总收入80,690.78万元,同比增长42.24%;实现归属于上市公司股东的净利润14,588.55万元,同比增长105.80%。2026年第一季度,公司实现营业收入22,962.89万元,同比增长21.33%,归属于上市公司股东的净利润5,447.67万元,同比增长47.21%,延续了良好的增长态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100008083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647223903","title":"山外山涨6.82%,中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647223903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647223903?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:39","pubTimestamp":1782722383,"startTime":"0","endTime":"0","summary":"今日山外山(688410)涨6.82%,收盘报14.57元。2026年5月8日,中邮证券研究员盛丽华发布了对山外山的研报《业绩持续高增,设备与耗材双轮驱动盈利向上》,该研报对山外山给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为77.13%。此外,太平洋研究员谭紫媚,李啸岩,信达证券研究员唐爱金近期也对该股发布了研报,同样给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为东北证券的文将儒、叶菁。山外山(688410)个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646501316","title":"每周股票复盘:山外山(688410)高管减持124.29万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646501316","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646501316?lang=zh_cn&edition=full","pubTime":"2026-06-28 04:17","pubTimestamp":1782591428,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,山外山报收于13.64元,较上周的14.51元下跌6.0%。本周,山外山6月23日盘中最高价报14.8元。本周关注点股本股东变化:董事高光勇减持124.29万股,占总股本0.3889%。股本股东变化:截至6月18日股东户数降至1.08万户,户均持股市值42.93万元。股东户数变动截至2026年6月18日,公司股东户数为1.08万户,较5月29日减少243户,减幅2.2%。户均持股数量由2.89万股上升至2.96万股,户均持股市值为42.93万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800001433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646124366","title":"山外山(688410)披露2026年员工持股计划完成非交易过户公告,6月26日股价下跌3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646124366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646124366?lang=zh_cn&edition=full","pubTime":"2026-06-26 23:07","pubTimestamp":1782486433,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,山外山报收于13.64元,较前一交易日下跌3.12%,最新总市值为43.59亿元。近日,重庆山外山血液净化技术股份有限公司披露《关于2026年员工持股计划完成非交易过户的公告》。公告显示,公司于2026年6月25日将1,666,341股公司股票非交易过户至2026年员工持股计划证券账户,过户价格为8.14元/股,占公司总股本的0.52%。本期员工持股计划实际参与认购员工为73人,缴纳资金总额13,564,015.74元,对应股份数量1,666,341股,股票来源为公司回购股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600046267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646984240","title":"【私募调研记录】磐耀资产调研山外山","url":"https://stock-news.laohu8.com/highlight/detail?id=2646984240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646984240?lang=zh_cn&edition=full","pubTime":"2026-06-25 08:12","pubTimestamp":1782346347,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月24日披露的机构调研信息,知名私募磐耀资产近期对1家上市公司进行了调研,相关名单如下:1)山外山 调研纪要:国产替代加速推进,2025年国产血液净化设备规模达11.9亿元,核心部件自给率90%。在投资方法上,磐耀资产注重研究驱动的投资,强调严谨科学的投资流程在投资中的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026062500006787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645811627","title":"山外山(688410)披露2026年员工持股计划第一次持有人会议决议公告,6月24日股价下跌1.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645811627","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645811627?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:52","pubTimestamp":1782312735,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘,山外山报收于14.24元,较前一交易日下跌1.93%,最新总市值为45.51亿元。该股当日开盘14.48元,最高14.57元,最低14.15元,成交额达7562.31万元,换手率为1.65%。近日,重庆山外山血液净化技术股份有限公司发布《2026年员工持股计划第一次持有人会议决议公告》。本次会议出席持有人73人,代表份额占总份额的96.10%,所有议案均获全票通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400044385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645191468","title":"山外山:公司通过全面推进募投项目建设,系统性地规划了未来产能提升路径","url":"https://stock-news.laohu8.com/highlight/detail?id=2645191468","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645191468?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:07","pubTimestamp":1782310020,"startTime":"0","endTime":"0","summary":"证券日报网6月24日讯 ,山外山在接受调研者提问时表示,公司围绕血液净化主业,通过全面推进募投项目建设,系统性地规划了未来产能提升路径。其中“血液净化设备及高值耗材产业化项目”预计建成后,每年可生产血液透析器1200万支,每年可生产智能血液透析机10000台,多器官生命支持系统2000台。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-24/doc-iniepqxq6088034.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-24/doc-iniepqxq6088034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645462819","title":"山外山:公司始终重视与投资者的沟通交流","url":"https://stock-news.laohu8.com/highlight/detail?id=2645462819","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645462819?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:06","pubTimestamp":1782309960,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯 6月24日,山外山在互动平台回答投资者提问时表示,公司于2026年5月12日参加了“十五五·科创惠民——科创板企业成果转化与民生赋能之2025年度医疗器械行业集体业绩说明会暨2026年第一季度业绩说明会”,就投资者关心的问题进行了交流。公司始终重视与投资者的沟通交流,积极通过定期报告、业绩说明会、投资者热线、互动易平台等多种方式与投资者保持沟通。未来公司将结合监管要求、会议组织安排、信息披露公平性及沟通效果等因素,持续评估并优化投资者沟通方式,努力提升投资者获取信息的便利性和充分性。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-24/doc-iniepqxm8118269.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-24/doc-iniepqxm8118269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645891549","title":"山外山:6月11日接受机构调研,华安基金、奇盛基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2645891549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645891549?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:54","pubTimestamp":1782294877,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年6月24日山外山发布公告称公司于2026年6月11日接受机构调研,华安基金、奇盛基金、东方财富证券参与。2026 年一季度公司血液净化设备实现营业收入 15,048.10 万元,同比增长18.03%。山外山2026年一季报显示,一季度公司主营收入2.3亿元,同比上升21.33%;归母净利润5447.67万元,同比上升47.21%;扣非净利润5092.1万元,同比上升45.69%;负债率22.96%,投资收益191.11万元,财务费用7.5万元,毛利率55.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400033638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645899677","title":"山外山(688410)6月18日股东户数1.08万户,较上期减少2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645899677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645899677?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:35","pubTimestamp":1782293740,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山外山披露,截至2026年6月18日公司股东户数为1.08万户,较5月29日减少243.0户,减幅为2.2%。在医疗器械行业个股中,山外山股东户数低于行业平均水平,截至6月18日,医疗器械行业平均股东户数为2.21万户。从股价来看,2026年5月29日至2026年6月18日,山外山区间跌幅为14.14%,在此期间股东户数减少243.0户,减幅为2.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400032269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024484","title":"山外山:6月18日董事高光勇减持股份合计124.29万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645024484?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:01","pubTimestamp":1782129706,"startTime":"0","endTime":"0","summary":"证券之星消息,根据6月22日市场公开信息、上市公司公告及交易所披露数据整理,山外山最新董监高及相关人员股份变动情况:2026年6月18日公司董事,高级管理人员,核心技术人员高光勇共减持公司股份124.29万股,占公司总股本为0.3889%。山外山近半年内的董监高及核心技术人员增减持详情如下:山外山的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出1180.42万,融资余额减少;融券净流入200.0,融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200034292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644306581","title":"每周股票复盘:高光勇减持山外山(688410)1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2644306581","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644306581?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:42","pubTimestamp":1781894532,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,山外山报收于14.51元,较上周的14.42元上涨0.62%。本周,山外山6月18日盘中最高价报14.86元。本周关注点股本股东变化:高光勇6月17日减持山外山84.0万股,占总股本0.2628%。股本股东变化高管增减持2026年6月17日,山外山董事、高级管理人员、核心技术人员高光勇减持公司股份84.0万股,占公司总股本0.2628%。本次减持计划已实施完毕,高光勇持股比例由24.39%降至23.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644659083","title":"山外山:6月17日董事高光勇减持股份合计84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644659083","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644659083?lang=zh_cn&edition=full","pubTime":"2026-06-18 20:02","pubTimestamp":1781784133,"startTime":"0","endTime":"0","summary":"证券之星消息,根据6月18日市场公开信息、上市公司公告及交易所披露数据整理,山外山最新董监高及相关人员股份变动情况:2026年6月17日公司董事,高级管理人员,核心技术人员高光勇共减持公司股份84.0万股,占公司总股本为0.2628%。山外山近半年内的董监高及核心技术人员增减持详情如下:山外山的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出482.4万,融资余额减少;融券净流入200.0,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800038679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643021740","title":"每周股票复盘:山外山(688410)股东户数增15.33%至1.1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2643021740","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643021740?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:42","pubTimestamp":1781372533,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘,山外山报收于14.42元,较上周的14.75元下跌2.24%。本周,山外山6月8日盘中最高价报14.61元。本周关注点股本股东变化:股东户数较3月31日增加15.33%,达1.1万户股本股东变化:户均持股数量由3.34万股降至2.89万股股本股东变化:户均持股市值为48.9万元股本股东变化股东户数变动截至2026年5月29日,公司股东户数为1.1万户,较3月31日增加1468.0户,增幅15.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127940","title":"每周股票复盘:山外山(688410)高管高光勇减持111.31万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127940","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127940?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:36","pubTimestamp":1780770971,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘,山外山报收于14.75元,较上周的16.9元下跌12.72%。本周,山外山6月1日盘中最高价报17.16元。6月5日盘中最低价报14.38元。山外山当前最新总市值47.14亿元,在医疗器械板块市值排名70/129,在两市A股市值排名3479/5206。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641116639","title":"山外山最新公告:全资子公司取得血液透析干粉医疗器械变更注册文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116639","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116639?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:45","pubTimestamp":1780649148,"startTime":"0","endTime":"0","summary":"山外山(688410.SH)公告称,公司全资子公司重庆天外天生物技术有限公司近日收到国家药监局颁发的医疗器械变更注册文件,产品为血液透析干粉,主要变更内容为产品技术要求。本次变更为常规合规性技术升级,不涉及核心配方及适用范围调整,有利于增强公司产品综合竞争力。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","159883","688410","BK0251","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640977331","title":"6月3日山外山跌7.22%,圆信永丰医药健康A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640977331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640977331?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:36","pubTimestamp":1780475803,"startTime":"0","endTime":"0","summary":"证券之星消息,6月3日山外山跌7.22%,收盘报15.29元,换手率3.55%,成交量11.36万手,成交额1.78亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为圆信永丰基金的圆信永丰医药健康A。圆信永丰医药健康A目前规模为2.66亿元,最新净值1.789,较上一交易日下跌1.79%,近一年上涨3.63%。圆信永丰医药健康A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09939","150219","688410","BK0251","BK1515","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783723641872,"stockEarnings":[{"period":"1week","weight":-0.0597},{"period":"1month","weight":0.0619},{"period":"3month","weight":-0.1046},{"period":"6month","weight":-0.0884},{"period":"1year","weight":0.0091},{"period":"ytd","weight":-0.0232}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.0025},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.1386},{"period":"ytd","weight":0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆山外山血液净化技术股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"10802人(较上一季度减少2.20%)","perCapita":"41422股","listingDate":"2022-12-26","address":"重庆市两江新区慈济路1号","registeredCapital":"44744万元","survey":" 重庆山外山血液净化技术股份有限公司的主营业务是血液净化设备与耗材的研发、生产和销售,并提供连锁血液透析医疗服务。公司的主要产品是血液灌流机、连续性血液净化设备、血液透析机、血液净化设备、血液透析浓缩液、血液透析干粉、血液透析器、透析液过滤器、连续性血液净化管路、一次性使用血液灌流器。公司形成了国家级企业技术中心、国家博士后科研工作站、国家地方联合工程研究中心等科技创新平台,先后荣获“国家科学技术进步奖二等奖”等多项国家级奖项,被评为“国家技术创新示范企业”。","listedPrice":32.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山外山(688410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山外山(688410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山外山,688410,山外山股票,山外山股票老虎,山外山股票老虎国际,山外山行情,山外山股票行情,山外山股价,山外山股市,山外山股票价格,山外山股票交易,山外山股票购买,山外山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山外山(688410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山外山(688410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}